Baird Says Itron (ITRI) is Ready for Long-Term Growth - Raises PT to $47
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Itron (ITRI) Is In the Early Stages of a Turnaround - Wedbush
February 18, 2016 9:47 AM ESTWedbush analyst, David Rose, thinks that Itron (NASDAQ: ITRI) is in the early stages of a turnaround, based on improving margins and an impressive bookings figure. There is still execution risk but the elements are in place with Q4 results providing good evidence... More
Itron (ITRI) Tops Q4 EPS by 2c, FY Revenue Guidance Comes in Light
February 17, 2016 4:10 PM ESTItron (NASDAQ: ITRI) reported Q4 EPS of $0.76, $0.02 better than the analyst estimate of $0.74. Revenue for the quarter came in at $490.4 million versus the consensus estimate of $486.56 million.
GUIDANCE:
Itron sees FY2016 EPS of $1.95-$2.25, versus the consensus of $2.13. Itron sees... More
Trading Radar for 2/17: Marriott (MAR), NVIDIA (NVDA), Priceline (PCLN), Barrick Gold (ABX), Albemarle (ALB) Report
February 16, 2016 3:29 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
9:15am EST
Industrial Production - Street sees 0.3%Capacity Utilization - Street sees 76.6%Earnings:
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.16
Albany Molecular Research (Nasdaq: AMRI) - consensus EPS $0.36... More
